Ethical dilemma for Ebola drug trials.
Erika Check
EC
Hayden
D000354:Africa, Western / Q000453:epidemiology; D000914:Antibodies, Viral / Q000276:immunology / Q000627:therapeutic use; D001788:Blood Grouping and Crossmatching; D057176:Compassionate Use Trials / Q000941:ethics / Q000592:standards; D018849:Controlled Clinical Trials as Topic / Q000941:ethics* / Q000592:standards; D029043:Ebolavirus / Q000276:immunology; D019317:Evidence-Based Medicine / Q000941:ethics* / Q000592:standards*; D019142:Hemorrhagic Fever, Ebola / Q000188:drug therapy / Q000453:epidemiology / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007106:Immune Sera / Q000276:immunology; D007116:Immunization, Passive; D009316:National Institutes of Health (U.S.); D011634:Public Health / Q000941:ethics; D016896:Treatment Outcome; D014481:United States; D014944:World Health Organization
D000914:Antibodies, Viral; D007106:Immune Sera